Inspire Medical Systems Stock Fundamentals
| INSP Stock | USD 199.32 10.59 5.61% |
Inspire Medical Systems fundamentals help investors to digest information that contributes to Inspire Medical's financial success or failures. It also enables traders to predict the movement of Inspire Stock. The fundamental analysis module provides a way to measure Inspire Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Inspire Medical stock.
At this time, Inspire Medical's Cost Of Revenue is relatively stable compared to the past year. As of 11/25/2024, Total Operating Expenses is likely to grow to about 596.9 M, while Operating Income is likely to drop (42.3 M). Inspire | Select Account or Indicator |
Inspire Medical Systems Company Profit Margin Analysis
Inspire Medical's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Inspire Medical Profit Margin | 0.04 % |
Most of Inspire Medical's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Inspire Medical Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Inspire Pretax Profit Margin
Pretax Profit Margin |
|
Based on the latest financial disclosure, Inspire Medical Systems has a Profit Margin of 0.0437%. This is 100.39% lower than that of the Health Care Technology sector and 100.8% lower than that of the Health Care industry. The profit margin for all United States stocks is 103.44% lower than that of the firm.
Inspire Medical Systems Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Inspire Medical's current stock value. Our valuation model uses many indicators to compare Inspire Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Inspire Medical competition to find correlations between indicators driving Inspire Medical's intrinsic value. More Info.Inspire Medical Systems is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.22 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Inspire Medical Systems is roughly 4.52 . At this time, Inspire Medical's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Inspire Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Inspire Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Inspire Medical's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Inspire Medical could also be used in its relative valuation, which is a method of valuing Inspire Medical by comparing valuation metrics of similar companies.Inspire Medical is currently under evaluation in profit margin category among its peers.
Inspire Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Inspire Medical from analyzing Inspire Medical's financial statements. These drivers represent accounts that assess Inspire Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Inspire Medical's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.8B | 4.9B | 6.3B | 7.1B | 6.0B | 6.3B | |
| Enterprise Value | 1.8B | 4.7B | 6.1B | 6.6B | 5.8B | 6.1B |
Inspire Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Inspire Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Inspire Medical's managers, analysts, and investors.Environmental | Governance | Social |
Inspire Fundamentals
| Return On Equity | 0.0533 | ||||
| Return On Asset | 0.0118 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 5.27 B | ||||
| Shares Outstanding | 29.97 M | ||||
| Shares Owned By Insiders | 1.94 % | ||||
| Shares Owned By Institutions | 98.06 % | ||||
| Number Of Shares Shorted | 1.95 M | ||||
| Price To Earning | 15.29 X | ||||
| Price To Book | 8.12 X | ||||
| Price To Sales | 7.49 X | ||||
| Revenue | 624.8 M | ||||
| Gross Profit | 341.74 M | ||||
| EBITDA | (40.27 M) | ||||
| Net Income | (21.15 M) | ||||
| Cash And Equivalents | 196.32 M | ||||
| Cash Per Share | 7.10 X | ||||
| Total Debt | 24.85 M | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 5.62 X | ||||
| Book Value Per Share | 23.25 X | ||||
| Cash Flow From Operations | 24.65 M | ||||
| Short Ratio | 5.07 X | ||||
| Earnings Per Share | 1.11 X | ||||
| Price To Earnings To Growth | (2.57) X | ||||
| Target Price | 239.87 | ||||
| Number Of Employees | 1.01 K | ||||
| Beta | 1.36 | ||||
| Market Capitalization | 5.66 B | ||||
| Total Asset | 676.81 M | ||||
| Retained Earnings | (345.42 M) | ||||
| Working Capital | 515.63 M | ||||
| Current Asset | 167.55 M | ||||
| Current Liabilities | 64.84 M | ||||
| Net Asset | 676.81 M |
About Inspire Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Inspire Medical Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inspire Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inspire Medical Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | -745.2 K | -782.5 K | |
| Total Revenue | 624.8 M | 656 M | |
| Cost Of Revenue | 96.6 M | 101.4 M | |
| Stock Based Compensation To Revenue | 0.13 | 0.14 | |
| Sales General And Administrative To Revenue | 0.56 | 0.56 | |
| Research And Ddevelopement To Revenue | 0.19 | 0.32 | |
| Capex To Revenue | 0.04 | 0.02 | |
| Revenue Per Share | 21.32 | 22.39 | |
| Ebit Per Revenue | (0.06) | (0.07) |
Pair Trading with Inspire Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inspire Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inspire Medical will appreciate offsetting losses from the drop in the long position's value.Moving against Inspire Stock
| 0.69 | DXCM | DexCom Inc | PairCorr |
| 0.61 | LH | Laboratory | PairCorr |
| 0.57 | VREX | Varex Imaging Corp | PairCorr |
| 0.54 | GH | Guardant Health | PairCorr |
| 0.46 | EW | Edwards Lifesciences Corp | PairCorr |
The ability to find closely correlated positions to Inspire Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inspire Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inspire Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inspire Medical Systems to buy it.
The correlation of Inspire Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inspire Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inspire Medical Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inspire Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Inspire Stock Analysis
When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.